BIODESIX INC

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• PBPaul Beresford, Ph.D.Executive Officer
• WBWendy BlosserExecutive Officer
• DBDavid BrunelDirector · Executive Officer
• RCRobert CawthornDirector
• BCBobbi CoffinExecutive Officer
• RCRobin CowieExecutive Officer
• LFLiz FliegelmanExecutive Officer
• JFJean FranchiDirector
• RGRobert GeorgantasExecutive Officer
• SHScott HuttonDirector · Executive Officer
• HMHany MassaranyDirector
• MMMark MillerDirector
• JPJohn PatienceDirector
• GPGary Pestano, Ph.D.Executive Officer
• JPJim PurvisExecutive Officer
• HRHeinrich RoderDirector · Executive Officer
• HRHeinrich Roder, D.PhilExecutive Officer
• HRHeinrich Roder, D.Phil.Executive Officer
• FRFrank RonchettiExecutive Officer
• JSJack SchulerDirector
• MSMatt StaufferExecutive Officer
• MSMatthew StrobeckDirector
• LTLinda Traylor, Ph.D.Executive Officer
• CWCharles WattsDirector

• 14 Apr 2026Interpretation Of Machine Learning Classifications In Clinical Diagnostics Using Shapley Values And Uses Thereofgranted
• 11 Dec 2025Sensitive And Accurate Feature Values From Deep Maldi Spectraapplication
• 11 Mar 2025Compositions, Methods And Kits For Diagnosis Of Lung Cancergranted
• 18 Feb 2025Predictive Test For Patient Benefit From Antibody Drug Blocking Ligand Activation Of The T-cell Programmed Cell Death 1 (PD-1) Checkpoint Protein And Classifier Development Methodsgranted
• 17 Sept 2024Apparatus And Method For Identification Of Primary Immune Resistance In Cancer Patientsgranted
• 27 Feb 2024Compositions, Methods And Kits For Diagnosis Of Lung Cancergranted
• 06 Feb 2024Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findingsgranted
• 25 Jul 2023Predictive Test for Melanoma Patient Benefit from Interleukin-2 (IL2) Therapygranted
• 22 Jun 2023Predictive Test For Prognosis Of Myelodysplastic Syndrome Patients Using Mass Spectrometry Of Blood-based Sampleapplication
• 04 Apr 2023Classifier Generation Methods and Predictive Test for Ovarian Cancer Patient Prognosis Under Platinum Chemotherapygranted
• 28 Feb 2023Predictive Test for Prognosis of Myelodysplastic Syndrome Patients Using Mass Spectrometry of Blood-Based Samplegranted
• 03 Jan 2023Antibodies Targeting Pulmonary Nodule Specific Biomarkers And Uses Thereofgranted

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.